HF Patient Decision Making Prior to Rehospitalization
心衰患者再住院前的决策
基本信息
- 批准号:8787020
- 负责人:
- 金额:$ 3.74万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2013
- 资助国家:美国
- 起止时间:2013-12-01 至 2015-08-31
- 项目状态:已结题
- 来源:
- 关键词:AcuteAddressAdmission activityAgeAgingAmerican Heart AssociationBehaviorCaringCharacteristicsChronic DiseaseComorbidityComplexDecision MakingDevelopmentEducationExhibitsFutureGoalsHealthHealth Care CostsHealthcare SystemsHeart failureHospitalizationHospitalsIndividualInterventionInterviewKnowledgeLeadMedicalMedical EducationMedicareMethodsModelingNational Institute of Nursing ResearchOutcomePatient-Centered CarePatientsPopulationProcessRaceReportingSelf CareStrategic PlanningSurveysUnited Statescostdesignhelp-seeking behaviorimprovedmedical attentionpatient orientedpreventprogramspublic health relevanceresponsesextelehealth
项目摘要
DESCRIPTION (provided by applicant): Rehospitalizations among heart failure (HF) patients are common due to a HF trajectory marked by sudden, acute exacerbations of illness. Nearly 1/5 of HF patients with Medicare are rehospitalized within 30 days of discharge, contributing to United States (US) HF costs of nearly 40 billion dollars a year. With the aging of the baby boomer population, these costs will rapidly increase in the future. Recent Medicare reimbursement changes place heavy penalties for 30 day hospitalizations related to HF, adding to the increasing financial burden of HF on the health care system. Despite efforts to prevent unnecessary HF hospitalizations through increased HF education, medical support after discharge, and telehealth programs, rehospitalization rates remain high. Current hospitalization prediction models for HF use patient characteristics (e.g. age, race, comorbidities) that do not consistently or strongly predict readmission -suggesting the need to examine and explore other patient characteristics such as medical decision making. Decision making in HF patients prior to being rehospitalized is complex, multifaceted, and poorly understood. In 2012, the American Heart Association (AHA) scientific report on decision making in advanced HF, identified the critical need for clinicians to understand HF patient decision making to promote effective, timely,
efficient, and safe patient-centered care. Additionally, it is unknown if decision making processes differ between HF patients who have been rehospitalized within and beyond 30 days. The main goal of the study is to compare: (1) HF self-care, (2) decisional delays, and (3) decisions prior to hospitalization between HF patients who are rehospitalized within and beyond 30 days. The study, guided by a modified naturalistic decision making framework, uses a convergent parallel mixed-methods design to gain an in-depth understanding of the HF patient's decision making process with a focus on the critical modifiable variables of self-care and decisional delay. HF patients will be asked to complete a survey and participate in an interview about their decision making prior to rehospitalization. The proposed study is directly aligned with
the National Institute of Nursing Research's (NINR) strategic plan to develop strategies that assist patients in better managing their chronic illness.
描述(由申请人提供):由于以疾病突然急性加重为标志的HF轨迹,心力衰竭(HF)患者的再住院很常见。近1/5的医疗保险HF患者在出院后30天内再次住院,导致美国(US)HF费用每年近400亿美元。随着婴儿潮一代人口的老龄化,这些成本将在未来迅速增加。最近的医疗保险报销变化对与HF相关的30天住院治疗进行了严厉的处罚,增加了HF对医疗保健系统的日益增加的经济负担。尽管通过增加HF教育、出院后医疗支持和远程医疗计划努力防止不必要的HF住院,但再住院率仍然很高。目前HF的住院预测模型使用的患者特征(例如年龄、种族、合并症)不能一致或强烈预测再入院-这表明需要检查和探索其他患者特征,例如医疗决策。心力衰竭患者在再次住院前的决策是复杂的、多方面的,而且人们对此知之甚少。2012年,美国心脏协会(AHA)关于晚期HF决策的科学报告指出,临床医生迫切需要了解HF患者的决策,以促进有效,及时,
高效安全的以病人为中心的护理此外,尚不清楚在30天内和30天后再次住院的HF患者之间的决策过程是否存在差异。本研究的主要目的是比较:(1)HF自我护理,(2)决策延迟,(3)在30天内和30天后再次住院的HF患者之间的住院前决策。这项研究,修改后的自然主义决策框架的指导下,使用收敛并行混合方法设计,以深入了解HF患者的决策过程,重点是自我护理和决策延迟的关键可变变量。HF患者将被要求完成一项调查,并参加一次关于其再住院前决策的访谈。拟议的研究直接与
国家护理研究所(NINR)的战略计划,以制定战略,帮助患者更好地管理他们的慢性疾病。
项目成果
期刊论文数量(1)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Finding Disseration RAs within a PhD Student's Budget.
在博士生的预算内寻找论文 RA。
- DOI:
- 发表时间:2014
- 期刊:
- 影响因子:0
- 作者:Xu,Jiayun;Han,Hae-Ra
- 通讯作者:Han,Hae-Ra
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Jiayun Xu其他文献
Jiayun Xu的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Jiayun Xu', 18)}}的其他基金
Preparing Patient-Caregiver Dyads with Parkinson's Disease for End-of-Life Decision Making
为患有帕金森病的患者和护理人员二人做好临终决策的准备
- 批准号:
10215969 - 财政年份:2021
- 资助金额:
$ 3.74万 - 项目类别:
Preparing Patient-Caregiver Dyads with Parkinson's Disease for End-of-Life Decision Making
为患有帕金森病的患者和护理人员二人做好临终决策的准备
- 批准号:
10456804 - 财政年份:2021
- 资助金额:
$ 3.74万 - 项目类别:
Preparing Patient-Caregiver Dyads with Parkinson's Disease for End-of-Life Decision Making
为患有帕金森病的患者和护理人员二人做好临终决策的准备
- 批准号:
10650777 - 财政年份:2021
- 资助金额:
$ 3.74万 - 项目类别:
HF Patient Decision Making Prior to Rehospitalization
心衰患者再住院前的决策
- 批准号:
8644983 - 财政年份:2013
- 资助金额:
$ 3.74万 - 项目类别:
相似海外基金
Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
- 批准号:
MR/S03398X/2 - 财政年份:2024
- 资助金额:
$ 3.74万 - 项目类别:
Fellowship
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
- 批准号:
EP/Y001486/1 - 财政年份:2024
- 资助金额:
$ 3.74万 - 项目类别:
Research Grant
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
- 批准号:
2338423 - 财政年份:2024
- 资助金额:
$ 3.74万 - 项目类别:
Continuing Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
- 批准号:
MR/X03657X/1 - 财政年份:2024
- 资助金额:
$ 3.74万 - 项目类别:
Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
- 批准号:
2348066 - 财政年份:2024
- 资助金额:
$ 3.74万 - 项目类别:
Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
- 批准号:
AH/Z505481/1 - 财政年份:2024
- 资助金额:
$ 3.74万 - 项目类别:
Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10107647 - 财政年份:2024
- 资助金额:
$ 3.74万 - 项目类别:
EU-Funded
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
- 批准号:
2341402 - 财政年份:2024
- 资助金额:
$ 3.74万 - 项目类别:
Standard Grant
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10106221 - 财政年份:2024
- 资助金额:
$ 3.74万 - 项目类别:
EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
- 批准号:
AH/Z505341/1 - 财政年份:2024
- 资助金额:
$ 3.74万 - 项目类别:
Research Grant